Reference Pts. number Med. age (range) Donors Disease Med. CD34 ×106 Med. CD3 ×108 O’Donnell et al., 2002 [24 ] 13 53 Parent 16% Sib 38% Child 46% AML/MDS 7 ALL 2 CML 2 MM 1 NHL 1 5.3 0.32 Luznik et al., 2008 [25 ] 68 46 Parent 28% Sib 48% Child 24% AML/MDS 28 ALL 4 CML/CMML 6 CLL/NHL 13 HL 13 MM 3 PNH 1 4.8 0.42 Symons et al., 2011 [26 ] 30 43 NA AML 16 3 ALL 2 CML 9 NHL NA NA Brunstein et al., 2011 [27 ] 50 48 Parent 30% Sib 34% Child 36% AML 22 ALL 9 NHL 12 HL 7 NA NA Pingali et al., 2014 [28 ] 84 46 Parent 15% Sib 42% Child 42% Cousin 1% AML/MDS 49 ALL 10 CML 9 Lymphoma 13 3 others NA NA Solomon et al., 2012 [29 ] 20 44 Parent 15% Sib 65% Child 20% AML 20 ALL 2 NHL 2 HL 1 CML 3 5 1.73 Raiola et al., 2013 [30 ] 50 42 NA AML 25 ALL 12 Lymphoma 5 MPD 5 CML 3 4 0.35 Raj et al., 2014 [31 ] 55 49 Parent 24% Sib 37% Child 39% AML/MDS 21 ALL 2 NHL 12 HL 9 6.4 2 Bhamidipati et al., 2014 [32 ] 18 41 Parent 28% Sib 33% Child 39% AML 12 ALL 2 NHL 2 Other 2 5 1.97
Castagna et al., 2014 [33 ] BM, (67%) 44 NA AML/MDS 2 ALL 2 HL 23 NHL/CLL 16 MM 2 3 0.34 PBSC, (33%) 54 NA AML/MDS 2 HL 6 NHL/CLL 12 MM 2 5.1 2.73 Solomon et al., 2015 [34 ] 30 46.5 Parent 7% Sib 40% Child 53% AML/MDS 17 ALL 6 CML 5 NHL 2 5.01 1.55
Bradstock et al., 2015 [35 ] BM, 53 Parent 7% Sib 66% Child 27% AML 10 NHL 2 CML 1 2.5 NA PBSC, 44 AML/MDS 11 NHL 4 ALL 4 Other 4 5.8 NA Gayoso et al., 2013 [36 ] 80 37 Parent 35% Sib 44% Child 21% AML/MDS 30 NHL 5 HL 29 ALL 9 Other 6 NA NA Sugita et al., 2015 [37 ] 31 48 Parent 22.6% Sib 29% Child 45.1% Other 3.2% AML/MDS 21 ALL 8 NHL 2 4.0 NA